[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FI953139A0 - Atovakonia käsittäviä farmaseuttisia koostumuksia - Google Patents

Atovakonia käsittäviä farmaseuttisia koostumuksia

Info

Publication number
FI953139A0
FI953139A0 FI953139A FI953139A FI953139A0 FI 953139 A0 FI953139 A0 FI 953139A0 FI 953139 A FI953139 A FI 953139A FI 953139 A FI953139 A FI 953139A FI 953139 A0 FI953139 A0 FI 953139A0
Authority
FI
Finland
Prior art keywords
atovaquone
pharmaceutical compositions
production
relates
improved bioavailability
Prior art date
Application number
FI953139A
Other languages
English (en)
Swedish (sv)
Other versions
FI953139A (fi
FI114007B (fi
Inventor
Alan Roy Dearn
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of FI953139A publication Critical patent/FI953139A/fi
Publication of FI953139A0 publication Critical patent/FI953139A0/fi
Application granted granted Critical
Publication of FI114007B publication Critical patent/FI114007B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Fertilizers (AREA)
FI953139A 1992-12-24 1995-06-22 Menetelmä atovakonia käsittävien mikrofluidisoitujen partikkelien valmistamiseksi FI114007B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9226905 1992-12-24
GB929226905A GB9226905D0 (en) 1992-12-24 1992-12-24 Pharmaceutical preparation
GB9302646 1993-12-23
PCT/GB1993/002646 WO1994014426A1 (en) 1992-12-24 1993-12-23 Atovaquone pharmaceutical compositions

Publications (3)

Publication Number Publication Date
FI953139A FI953139A (fi) 1995-06-22
FI953139A0 true FI953139A0 (fi) 1995-06-22
FI114007B FI114007B (fi) 2004-07-30

Family

ID=10727175

Family Applications (1)

Application Number Title Priority Date Filing Date
FI953139A FI114007B (fi) 1992-12-24 1995-06-22 Menetelmä atovakonia käsittävien mikrofluidisoitujen partikkelien valmistamiseksi

Country Status (36)

Country Link
US (2) US6018080A (fi)
EP (1) EP0675711B1 (fi)
JP (1) JP3461353B2 (fi)
KR (1) KR0175193B1 (fi)
CN (1) CN1076194C (fi)
AT (1) ATE169215T1 (fi)
AU (2) AU675102B2 (fi)
BG (1) BG61932B1 (fi)
BR (1) BR9307719A (fi)
CA (1) CA2152615C (fi)
CZ (1) CZ289701B6 (fi)
DE (1) DE69320208T2 (fi)
DK (1) DK0675711T3 (fi)
ES (1) ES2122223T3 (fi)
FI (1) FI114007B (fi)
GB (1) GB9226905D0 (fi)
GE (1) GEP19991515B (fi)
HK (1) HK1004086A1 (fi)
HR (1) HRP931516B1 (fi)
HU (1) HU220215B (fi)
IL (1) IL108154A (fi)
MY (1) MY109990A (fi)
NO (1) NO316745B1 (fi)
NZ (1) NZ258995A (fi)
PL (1) PL175374B1 (fi)
RO (1) RO119686B1 (fi)
RU (1) RU2127585C1 (fi)
SA (1) SA94140644B1 (fi)
SG (1) SG43901A1 (fi)
SI (1) SI9300678A (fi)
SK (1) SK281924B6 (fi)
TW (2) TW443935B (fi)
UA (1) UA39879C2 (fi)
WO (1) WO1994014426A1 (fi)
YU (1) YU48919B (fi)
ZA (1) ZA939673B (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
GB9226905D0 (en) * 1992-12-24 1993-02-17 Wellcome Found Pharmaceutical preparation
WO1996013254A1 (en) * 1994-10-26 1996-05-09 Glaxo Wellcome House Pharmaceutical composition comprising atovaquone
DE4440337A1 (de) * 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
GB9424013D0 (en) * 1994-11-29 1995-01-18 Wellcome Found Medicaments
ATE265846T1 (de) * 1998-02-25 2004-05-15 Abbott Lab Butorphanol enthaltende formulierungen mit verzögerter freisetzung
US6503949B1 (en) 1999-05-17 2003-01-07 Noro Nordisk A/S Glucagon antagonists/inverse agonists
US6562807B2 (en) 2000-06-23 2003-05-13 Novo Nordisk A/S Glucagon antagonists/inverse agonists
WO2002040445A1 (en) 2000-11-17 2002-05-23 Novo Nordisk A/S Glucagon antagonists/inverse agonists
US6821960B2 (en) 2000-11-17 2004-11-23 Noyo Nordisk Pharmaceuticals, Inc. Glucagon antagonists/inverse agonists
US6706744B2 (en) 2000-11-17 2004-03-16 Novo Nordisk A/S Glucagon antagonists/inverse agonists
US6762318B2 (en) 2001-12-03 2004-07-13 Novo Nordisk A/S Glucagon antagonists
US6881746B2 (en) 2001-12-03 2005-04-19 Novo Nordick A/S Glucagon antagonists/inverse agonists
US7183518B2 (en) * 2004-09-24 2007-02-27 Michael Near System of food storage preparation and delivery in finished cooked state
DE102005011786A1 (de) * 2005-03-11 2006-09-14 Pharmasol Gmbh Verfahren zur Herstellung ultrafeiner Submicron-Suspensionen
CA2604770C (en) * 2005-04-13 2013-09-24 Abbott Gmbh & Co. Kg Method for carefully producing ultrafine particle suspensions and ultrafine particles and use thereof
US20080241254A1 (en) * 2007-01-02 2008-10-02 Suryakant Navale Pharmaceutical composition comprising atovaquone particles
DE102007001473A1 (de) 2007-01-08 2008-07-10 Andreas Lemke Verfahren zur Herstellung und Anwendung von Mikro- und/oder Nanosuspensionen durch aufbauende Mikronisierung in Gegenwart von Trockeneis und hohem Druck
WO2009007991A2 (en) * 2007-04-19 2009-01-15 Ipca Laboratories Limited A new process for preparation of atovaquone and novel intermediates thereof
AU2009273747A1 (en) * 2008-07-25 2010-01-28 Alphapharm Pty Ltd Atovaquone with a particle size diameter range (D90) of greater than 3 um to about 10 um
US20100099776A1 (en) * 2008-10-20 2010-04-22 Ranbaxy Laboratories Limited Oily suspension of atovaquone
WO2011021230A2 (en) 2009-08-20 2011-02-24 Ipca Laboratories Limited Novel complex for treatment and/or prophylaxis of parasitic infections
JP6310636B2 (ja) 2009-11-10 2018-04-11 セルジーン コーポレイション マイクロ流体化処理によって作製された難溶性薬物のナノ懸濁液
WO2011151418A2 (en) 2010-06-02 2011-12-08 Abbott Gmbh & Co. Kg Nanosusupension formulation comprising a polydimethylsiloxane hydrophobic phase
AU2013361292A1 (en) 2012-12-19 2015-07-09 Kashiv Pharma, Llc Supersaturated stabilized nanoparticles for poorly soluble drugs
WO2015071841A1 (en) 2013-11-12 2015-05-21 Druggability Technologies Holdings Limited Complexes of dabigatran and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them
BR112018076184A2 (pt) * 2016-06-16 2019-03-26 The University Of Liverpool composição sólida, composição farmacêutica ou veterinária na forma injetável, formulação intramuscularmente injetável, formulação subcutaneamente injetável, dispersão aquosa, dispersão oleosa, processos para preparar uma composição sólida, uma dispersão aquosa e uma dispersão oleosa, métodos para tratar e/ou prevenir uma infecção parasítica ou fúngica e para prevenir malária, e, kit para preparação de uma formulação líquida estéril de nanopartículas de atovaquona para injeção.
US20220265566A1 (en) * 2018-10-18 2022-08-25 Tulex Pharmaceuticals Inc. Atovaquone nanoparticulate compositions

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2533648A (en) * 1949-03-05 1950-12-12 Joseph H Warburg Circular saw making
NL6411993A (fi) * 1963-10-18 1965-04-20
US3347830A (en) * 1964-07-30 1967-10-17 Grace W R & Co Process of polymerizing formaldehyde
GB1141735A (en) * 1966-11-23 1969-01-29 Pfizer & Co C Pharmaceutical anti-tumor composition
US3655699A (en) * 1970-03-02 1972-04-11 Pfizer Analogues of lapachol as antitumor agents
US4107288A (en) 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
DE2601458A1 (de) * 1975-01-20 1976-07-22 Ciba Geigy Ag Loesliche, von phenylindandiaminen abgeleitete polyamide
PT68813A (en) * 1977-11-22 1978-12-01 Wellcome Found Anti-theilerial naphthoquinones
US4485117A (en) 1981-10-16 1984-11-27 Hudson Alan T Antiprotozoal compounds
US4485116A (en) * 1981-10-16 1984-11-27 Hudson Alan T Antiprotozoal compounds
DE3141691A1 (de) * 1981-10-21 1983-05-19 Hoechst Ag, 6230 Frankfurt Plasmid pac 1, verfahren zu seiner gewinnung und seine verwendung
GB8310141D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Naphthoquinone derivatives
GB8310140D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Antiprotozoal agents
US5175319A (en) 1983-04-14 1992-12-29 Burroughs Wellcome Co. Naphthoquinone derivatives
US5053432A (en) * 1983-04-14 1991-10-01 Burroughs Wellcome Co. Naphthoquinone derivatives
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
PL276385A1 (en) * 1987-01-30 1989-07-24 Exxon Chemical Patents Inc Method for polymerization of olefines,diolefins and acetylene unsaturated compounds
IL85097A (en) * 1987-01-30 1992-02-16 Exxon Chemical Patents Inc Catalysts based on derivatives of a bis(cyclopentadienyl)group ivb metal compound,their preparation and their use in polymerization processes
US4783389A (en) * 1987-03-27 1988-11-08 E. I. Du Pont De Nemours And Company Process for preparation of liquid electrostatic developers
US5155080A (en) * 1988-07-15 1992-10-13 Fina Technology, Inc. Process and catalyst for producing syndiotactic polyolefins
US5225500A (en) * 1988-07-15 1993-07-06 Fina Technology, Inc. Process and catalyst for producing syndiotactic polyolefins
US5225184A (en) * 1988-08-16 1993-07-06 Burroughs Wellcome Co. Medicaments
US5206268A (en) * 1988-08-16 1993-04-27 Burroughs Wellcome Co. Medicaments
GB8819477D0 (en) * 1988-08-16 1988-09-21 Wellcome Found Medicaments
FI893835A (fi) * 1988-08-16 1990-02-17 Wellcome Found Laekemedel.
KR930002411B1 (ko) * 1988-09-14 1993-03-30 미쓰이세끼유 가가꾸고오교오 가부시끼가이샤 벤젠불용성 유기알루미늄 옥시화합물 및 그 제조방법
GB8921516D0 (en) * 1989-09-22 1989-11-08 Wellcome Found Medicaments
ATE137770T1 (de) * 1989-10-10 1996-05-15 Fina Technology Metallocenkatalysator mit lewissäure und alkylaluminium
GB8923254D0 (en) * 1989-10-16 1989-12-06 Wellcome Found Medicaments
DE69026679T3 (de) * 1989-10-30 2005-10-06 Fina Technology, Inc., Houston Addition von Alkylaluminium zum Verbessern eines Metallocenkatalysators
US5387568A (en) * 1989-10-30 1995-02-07 Fina Technology, Inc. Preparation of metallocene catalysts for polymerization of olefins
DE3942363A1 (de) * 1989-12-21 1991-06-27 Hoechst Ag Verfahren zur herstellung einer polypropylen-formmasse
JP2545006B2 (ja) * 1990-07-03 1996-10-16 ザ ダウ ケミカル カンパニー 付加重合触媒
JP3076619B2 (ja) 1991-05-14 2000-08-14 三井化学株式会社 ブロック共重合体の製造方法
GB9226905D0 (en) * 1992-12-24 1993-02-17 Wellcome Found Pharmaceutical preparation
US5510118A (en) 1995-02-14 1996-04-23 Nanosystems Llc Process for preparing therapeutic compositions containing nanoparticles
US5766522A (en) * 1996-07-19 1998-06-16 Morton International, Inc. Continuous processing of powder coating compositions
US5976578A (en) * 1996-10-10 1999-11-02 Mcneil-Ppc, Inc. Liquid antacid compositions
US5914135A (en) * 1997-04-16 1999-06-22 Mcneil-Ppc, Inc. Liquid antacid compositions

Also Published As

Publication number Publication date
GEP19991515B (en) 1999-03-05
CN1076194C (zh) 2001-12-19
EP0675711A1 (en) 1995-10-11
PL309629A1 (en) 1995-10-30
DE69320208T2 (de) 1999-01-21
IL108154A0 (en) 1994-04-12
HUT71528A (en) 1995-12-28
YU48919B (sh) 2002-11-15
SK82895A3 (en) 1995-11-08
RU2127585C1 (ru) 1999-03-20
KR0175193B1 (ko) 1999-02-01
AU696662B2 (en) 1998-09-17
HRP931516B1 (en) 1999-04-30
SK281924B6 (sk) 2001-09-11
US6649659B1 (en) 2003-11-18
EP0675711B1 (en) 1998-08-05
CN1103290A (zh) 1995-06-07
BG99723A (bg) 1996-01-31
ATE169215T1 (de) 1998-08-15
AU675102B2 (en) 1997-01-23
FI953139A (fi) 1995-06-22
SA94140644B1 (ar) 2005-06-14
NO316745B1 (no) 2004-04-26
BR9307719A (pt) 1999-08-31
JP3461353B2 (ja) 2003-10-27
TW443935B (en) 2001-07-01
HK1004086A1 (en) 1998-11-13
MY109990A (en) 1997-10-31
DE69320208D1 (de) 1998-09-10
RO119686B1 (ro) 2005-02-28
KR950703942A (ko) 1995-11-17
HRP931516A2 (en) 1995-10-31
US6018080A (en) 2000-01-25
CZ289701B6 (cs) 2002-03-13
YU80893A (sh) 1997-03-07
HU220215B (hu) 2001-11-28
IL108154A (en) 2000-02-17
ZA939673B (en) 1995-06-23
AU5710594A (en) 1994-07-19
TW514531B (en) 2002-12-21
SI9300678A (en) 1994-09-30
DK0675711T3 (da) 1999-05-03
CZ145195A3 (en) 1995-10-18
BG61932B1 (bg) 1998-10-30
UA39879C2 (uk) 2001-07-16
NO952522D0 (no) 1995-06-22
SG43901A1 (en) 1997-11-14
HU9501812D0 (en) 1995-08-28
WO1994014426A1 (en) 1994-07-07
FI114007B (fi) 2004-07-30
NO952522L (no) 1995-06-22
ES2122223T3 (es) 1998-12-16
AU1627997A (en) 1997-05-22
NZ258995A (en) 1997-01-29
GB9226905D0 (en) 1993-02-17
CA2152615C (en) 2001-10-16
JPH08504805A (ja) 1996-05-28
CA2152615A1 (en) 1994-07-07
PL175374B1 (pl) 1998-12-31

Similar Documents

Publication Publication Date Title
FI953139A (fi) Atovakonia käsittäviä farmaseuttisia koostumuksia
HUT65278A (en) Process for producing pyrido-, pyrrolo-, thiazino-, oxazino- and pyrazino-benzazepine derivatives and pharmaceutical preparations containing them
FI101303B (fi) Menetelmä terapeuttisesti käyttökelpoisten 7-(2-tio-2-okso)metyyliamin o-5-okso-pyrrolo- ja -6-okso-pyrido- ja -pyratsino£2,1-a|£2|bentsatsep iini- ja -oksatsino- ja -tiatsino£3,4-a|£2|bentsatsepiini-4-karboksyyl ihappojohdannaisten valmistamiseksi
UA32543C2 (uk) Арилацетаміди, що мають анальгетичну дію, спосіб їх одержання, фармацевтична композиція та спосіб її одержання
DE3571982D1 (en) Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds
DK0579996T3 (da) 5,10-Methylentetrahydrofolsyrecyclodextrin-inklusionsforbindelser
HU9201789D0 (en) Process for the production of substituted diamino-phtalimides and their analogues
ES8606259A1 (es) Un metodo de producir una composicion farmaceutica que contiene isoxicamato de l-arginina como ingrediente activo.
HUT35694A (en) Process for producing 2'-deoxy-oxanosine and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
MA Patent expired